カテゴリ： GlobalData, イギリス, 企業調査

Oxford Nanopore Technologies Ltd：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Oxford Nanopore Technologies Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7371
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：60
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., develops disruptive, electronic, and single-molecule sensing system. The company’s products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its products find applications in various areas of research including microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research. The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, Oxfordshire, the UK.

Oxford Nanopore Technologies Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Oxford Nanopore Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Oxford Nanopore Technologies Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
Oxford Nanopore Raises US$64 Million In Venture Financing 11
Oxford Nanopore Technologies Raises US$50.8 Million In Venture Financing 13
Private Equity 14
Oxford Nanopore Tech Raises USD140 Million in Financing 14
Equity Offering 15
Oxford Nanopore Technologies Raises USD125.7 Million in Private Placement of Shares 15
Oxford Nanopore Raises USD109 Million in Private Placement of Shares 16
Oxford Nanopore Raises USD59 Million in Private Placement of Shares 17
Acquisition 18
Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For US$91 Million 18
Oxford Nanopore Technologies Ltd – Key Competitors 19
Oxford Nanopore Technologies Ltd – Key Employees 20
Oxford Nanopore Technologies Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Legal and Regulatory 22
May 09, 2018: Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences 22
Mar 22, 2018: Pacific Biosciences Prevails in Patent Eligibility Ruling Against Oxford Nanopore 23
Feb 08, 2018: Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore 24
Feb 08, 2018: Oxford Nanopore Successfully Defends PacBio lawsuit 25
Jan 22, 2018: Two new Oxford Nanopore Service providers: now cover US, China, Europe, Australia 26
Dec 10, 2017: Oxford Nanopore sequencing now available as a service: first two providers achieve certification 27
Sep 29, 2017: Response from Oxford Nanopore to new lawsuit from PacBio 28
Apr 21, 2017: Oxford Nanopore initiates legal proceedings against Pacific Biosciences 29
Mar 20, 2017: Oxford Nanopore responds to new, meritless lawsuit, delivered by PacBio one day after GridION launch 30
Feb 03, 2017: Response to UK Pacific Biosciences suit 31
Product News 32
May 10, 2018: New MinKNOW: software release makes nanopore sequencing better and easier 32
Apr 20, 2018: “Flu virus finally sequenced in its native form” using nanopore technology 33
Feb 23, 2018: PromethION in the wild: high yield data announcements in human and plant DNA 34
Feb 08, 2018: Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore 35
Jan 29, 2018: Most complete human genome assembly to date: Nature Biotech paper uses Oxford Nanopore MinION 36
Dec 27, 2017: World first: continuous DNA sequence of more than a million bases achieved with nanopore sequencing 37
Nov 26, 2017: New applications posters released for Nanopore Community Meeting 38
Nov 16, 2017: One step closer to abolishing the cold chain: lyophilised kits for field-based sequencing 40
Oct 18, 2017: Oxford Nanopore at ASHG 2017 41
Oct 18, 2017: Oxford Nanopore RNA analysis: 7x less data and 50x fewer reads needed, very low GC bias 43
Oct 17, 2017: Oxford Nanopore starts developer programme to trial new enrichment methods for real time nanopore sequencing 44
Oct 12, 2017: China welcomes Oxford Nanopore technology 45
Sep 04, 2017: New basecaller now performs ‘raw basecalling’, for improved sequencing accuracy 46
Aug 17, 2017: Oxford Nanopore provides update on GridION X5 47
Jun 26, 2017: Oxford Nanopore launches cDNA analysis, for full length transcripts 48
May 09, 2017: 1D squared kit available in the store: boost accuracy, simple prep 49
Apr 24, 2017: Oxford Nanopore launches analysis workflow for antimicrobial resistance 50
Apr 19, 2017: Direct RNA sequencing with nanopore opens up to more users 51
Mar 14, 2017: Introducing GridION X5 52
Mar 14, 2017: Oxford Nanopore Technologies: Introducing GridION X5 53
Feb 16, 2017: MinION software (MinKNOW) upgraded to enable increased data yield, other benefits 54
Feb 16, 2017: Oxford Nanopore Technologies: Response to UK Pacific Biosciences suit 55
Other Significant Developments 56
Sep 18, 2018: KCCG installs their PromethION sequencer 56
Jul 02, 2018: GrandOmics becomes the first certified PromethION service provider in China 57
Apr 24, 2018: Nanopore service providers update: three new providers, and more 58
Jan 27, 2018: Oxford Nanopore Technologies: Sequence from as little as 10pg starting material 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
Oxford Nanopore Technologies Ltd, Medical Equipment, Key Facts 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Oxford Nanopore Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Oxford Nanopore Technologies Ltd, Deals By Market, 2012 to YTD 2018 9
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Oxford Nanopore Raises US$64 Million In Venture Financing 11
Oxford Nanopore Technologies Raises US$50.8 Million In Venture Financing 13
Oxford Nanopore Tech Raises USD140 Million in Financing 14
Oxford Nanopore Technologies Raises USD125.7 Million in Private Placement of Shares 15
Oxford Nanopore Raises USD109 Million in Private Placement of Shares 16
Oxford Nanopore Raises USD59 Million in Private Placement of Shares 17
Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For US$91 Million 18
Oxford Nanopore Technologies Ltd, Key Competitors 19
Oxford Nanopore Technologies Ltd, Key Employees 20
Oxford Nanopore Technologies Ltd, Other Locations 21

List of Figures
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Oxford Nanopore Technologies Ltd：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • NaviNet Inc：企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Enel Americas SA：企業の戦略・SWOT・財務分析
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • New York Independent System Operator Inc：企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • BB Biotech AG (BION)：企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) operates as a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and meta …
  • Scotiabank Private Banking：企業の戦略・SWOT・財務情報
    Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • EuroSibEnergo Plc：企業の戦略的SWOT分析
    EuroSibEnergo Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • LifeTech Scientific Corporation (1302)：医療機器：M&Aディール及び事業提携情報
    Summary LifeTech Scientific Corporation (LifeTech Scientific) is a manufacturer, suppler and marketer of interventional medical devices for cardiovascular diseases. The product portfolio of the company includes occluders, stent graft system, delivery system, vena cava fitter, vascular plug, sizzing …
  • Discovery Communications, Inc.：企業の戦略・SWOT・財務情報
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Chrono Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Chrono Therapeutics Inc (CTI) is a personalized medicine manufacturer that provides programmable passive transdermal drug delivery products. The company provides smartstop, a programmable smoking cessation therapy that helps people to quit smoking and improve cessation outcomes. Its wearable …
  • Wartsila Corporation (WRT1V)：電力：M&Aディール及び事業提携情報
    Summary Wartsila Corporation (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vess …
  • Glide Pharmaceutical Technologies Ltd-医療機器分野：企業M&A・提携分析
    Summary Glide Pharmaceutical Technologies Ltd (Glide Technologies), formerly Caretek Medical Ltd, is a clinical stage development company that concentrates on development and delivery of solid dose formulations of vaccines and therapeutics. Its technology portfolio includes Glide SDI, a solid dose i …
  • Illumina Inc (ILMN)：医療機器：M&Aディール及び事業提携情報
    Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microar …
  • Nufarm Limited (NUF)：企業の財務・戦略的SWOT分析
    Nufarm Limited (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Allied Technologies Limited：企業のM&A・事業提携・投資動向
    Allied Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allied Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Confused.Com Limited
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Petroleo Brasileiro SA (PETR4)：企業の財務・戦略的SWOT分析
    Petroleo Brasileiro SA (PETR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Silvercorp Metals Inc.：企業の戦略・SWOT・財務情報
    Silvercorp Metals Inc. - Strategy, SWOT and Corporate Finance Report Summary Silvercorp Metals Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PCI Biotech Holding ASA (PCIB)：企業の財務・戦略的SWOT分析
    Summary PCI Biotech Holding ASA (PCI Biotech) is a biopharmaceutical company that focus on development and commercialisation of novel therapies for the treatment of cancer. The company develops therapeutic products based on its proprietary photochemical internalisation technology. Its lead product c …
  • Omega Protein Corporation：企業の戦略・SWOT・財務情報
    Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report Summary Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Comet Ridge Ltd (COI)：石油・ガス：M&Aディール及び事業提携情報
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆